Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 6
2013 13
2014 6
2015 8
2016 10
2017 15
2018 20
2019 17
2020 28
2021 44
2022 28
2023 26
2024 26
2025 31
2026 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Watanabe H, et al. Among authors: takagi k. JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145. JAMA. 2019. PMID: 31237644 Free PMC article. Clinical Trial.
MAIN OUTCOMES AND MEASURES: The primary end point was a composite of cardiovascular death, myocardial infarction (MI), ischemic or hemorrhagic stroke, definite stent thrombosis, or major or minor bleeding at 12 months, with a relative noninferiority margin of 50%. The majo …
MAIN OUTCOMES AND MEASURES: The primary end point was a composite of cardiovascular death, myocardial infarction (MI), ischemic or he …
Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals.
Kataoka Y, Ray KK, Nicholls SJ, Katasako-Yabumoto A, Kitahara S, Hosoda H, Mitsui K, Murai K, Sawada K, Matama H, Iwai T, Honda S, Fujino M, Yoneda S, Nakao K, Takagi K, Asaumi Y, Noguchi T. Kataoka Y, et al. Among authors: takagi k. Eur Heart J. 2026 May 24:ehag446. doi: 10.1093/eurheartj/ehag446. Online ahead of print. Eur Heart J. 2026. PMID: 42177636 Free article.
METHODS: Multicentre retrospective observational study analysing 1581 Japanese patients with CAD [Lp(a)-JAPAN: jRCT1050260016]. Risk of major adverse cardiovascular events (MACE) (cardiac death + non-fatal myocardial infarction + coronary revascularization in non-culprit s …
METHODS: Multicentre retrospective observational study analysing 1581 Japanese patients with CAD [Lp(a)-JAPAN: jRCT1050260016]. Risk of majo …
Valve Performance Between Latest-Generation Balloon-Expandable and Self-Expandable Transcatheter Heart Valves in a Small Aortic Annulus.
Hioki H, Yamamoto M, Shirai S, Ohno Y, Yashima F, Naganuma T, Yamawaki M, Watanabe Y, Yamanaka F, Mizutani K, Ryuzaki T, Noguchi M, Izumo M, Takagi K, Asami M, Ueno H, Nishina H, Otsuka T, Suzuyama H, Yamasaki K, Nishioka K, Hachinohe D, Fuku Y, Hayashida K; OCEAN-TAVI Investigators. Hioki H, et al. Among authors: takagi k. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2612-2622. doi: 10.1016/j.jcin.2024.08.049. JACC Cardiovasc Interv. 2024. PMID: 39603775 Free article.
Heart-Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke: Characteristics of Guideline-Recommended Coronary Revascularization and Antithrombotic Therapy and Cardiovascular and Bleeding Outcomes.
Suzuki T, Kataoka Y, Shiozawa M, Morris K, Kiyoshige E, Nishimura K, Murai K, Sawada K, Iwai T, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Koga M, Ihara M, Toyoda K, Tsujita K, Noguchi T. Suzuki T, et al. Among authors: takagi k. J Am Heart Assoc. 2023 Jan 17;12(2):e027156. doi: 10.1161/JAHA.122.027156. Epub 2023 Jan 16. J Am Heart Assoc. 2023. PMID: 36645078 Free PMC article.
The Heart-brain team approach has a potential to appropriately manage this poststroke cardiovascular complication. However, clinical outcomes of AMI complicating acute stroke (AMI-CAS) with the heart-brain team approach have not been characterized. The current study invest …
The Heart-brain team approach has a potential to appropriately manage this poststroke cardiovascular complication. However, clinical …
Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy.
Hayashi H, Kataoka Y, Murai K, Sawada K, Iwai T, Matama H, Honda S, Fujino M, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Izumiya Y, Fukuda D, Noguchi T. Hayashi H, et al. Among authors: takagi k. Cardiovasc Diagn Ther. 2022 Dec;12(6):803-814. doi: 10.21037/cdt-22-306. Cardiovasc Diagn Ther. 2022. PMID: 36605075 Free PMC article.
BACKGROUND: Active cancer associates with increased cardiovascular and bleeding risks in patients with acute myocardial infarction (AMI). Recent chemotherapeutic agents have improved survival rate which enables to induce inactive status of cancer. However, whether cardi …
BACKGROUND: Active cancer associates with increased cardiovascular and bleeding risks in patients with acute myocardial infarction (A …
Association Between Direct Oral Anticoagulant Score and Bleeding Events in Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: A Retrospective Multicenter Cohort Study.
Harano Y, Yamamoto M, Shimura T, Okubo M, Koyama Y, Yamaguchi R, Kagase A, Tokuda T, Yashima F, Shirai S, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Mizutani K, Noguchi M, Ueno H, Takagi K, Ohno Y, Izumo M, Nishina H, Asami M, Otsuka T, Watanabe Y, Hayashida K; OCEAN‐TAVI investigators †. Harano Y, et al. Among authors: takagi k. J Am Heart Assoc. 2024 Nov 19;13(22):e036417. doi: 10.1161/JAHA.124.036417. Epub 2024 Nov 7. J Am Heart Assoc. 2024. PMID: 39508173 Free PMC article.
Intra- versus supra-annular self-expanding transcatheter heart valves in small aortic annuli.
Yamamoto M, Ryuzaki T, Hioki H, Kagase A, Shirai S, Ohno Y, Yashima F, Naganuma T, Yamawaki M, Watanabe Y, Yamanaka F, Mizutani K, Noguchi M, Izumo M, Takagi K, Asami M, Ueno H, Nishina H, Suzuyama H, Yamasaki K, Nishioka K, Hachinohe D, Fuku Y, Otsuka T, Hayashida K, Ocean-Tavi Investigators OBOT. Yamamoto M, et al. Among authors: takagi k. EuroIntervention. 2025 Jul 7;21(13):e749-e757. doi: 10.4244/EIJ-D-24-00966. EuroIntervention. 2025. PMID: 40627007 Free PMC article.
When Should Chimney Stenting Be Performed?
Takagi K, Mitsui K, Asaumi Y. Takagi K, et al. Circ Rep. 2026 Jun 4;8(7):1176-1178. doi: 10.1253/circrep.CR-26-0172. eCollection 2026 Jul 10. Circ Rep. 2026. PMID: 42428627 Free PMC article. No abstract available.
Safety and Prognostic Implications of Mechanical Circulatory Support-Assisted Transcatheter Edge-to-Edge Repair: The OCEAN-Mitral Registry.
Tanaka S, Imamura T, Ushijima R, Nakamura M, Fukuda N, Ueno H, Kinugawa K, Yamamoto M, Kubo S, Izumi Y, Saji M, Asami M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Otsuki H, Naganuma T, Bota H, Ohno Y, Yamawaki M, Nakazawa G, Hachinohe D, Otsuka T, Hayashida K; OCEAN‐Mitral investigators. Tanaka S, et al. J Am Heart Assoc. 2025 Dec 16;14(24):e042785. doi: 10.1161/JAHA.125.042785. Epub 2025 Dec 10. J Am Heart Assoc. 2025. PMID: 41368845 Free PMC article.
In a landmark analysis starting from discharge date, there was no statistically significant difference in cardiovascular death or heart failure hospitalization between the groups with or without the use of MCS (hazard ratio, 1.45 [95% CI, 0.93-2.26]; P=0.10). ...
In a landmark analysis starting from discharge date, there was no statistically significant difference in cardiovascular death or hea …
241 results